Vimarsana
Biggest News Aggregation in the World

Page 7 - Grant Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grant Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grant Date Today - Breaking & Trending Today

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Agenus Inc. , a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the Compensation Committee of Agenus’ Board of Directors granted, as...

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the Compensation Committee of Agenus' Board of Directors granted, as of January 2, 2024 ("Grant Date"),...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, granted equity awards on December 29, 2023 that were previously approved by the Compensation Committee of its...

ELDORADO GOLD : AMENDED AND RESTATED PERFORMANCE SHARE UNIT PLAN - Form 6-K -December 15, 2023 at 02:17 pm EST - Vimarsana News

ELDORADO GOLD : AMENDED AND RESTATED PERFORMANCE SHARE UNIT PLAN - Form 6-K -December 15, 2023 at 02:17 pm EST

ELDORADO GOLD CORPORATION AMENDED AND RESTATED PERFORMANCE SHARE UNIT PLAN for Designated Participants as approved by Shareholders as of June 10,...

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 52,000 shares of...